Barclays’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $434K | Sell |
76,401
-8,364
| -10% | -$47.5K | ﹤0.01% | 3106 |
|
|
2025
Q1 | $403K | Buy |
84,765
+28,649
| +51% | +$136K | ﹤0.01% | 2954 |
|
|
2024
Q4 | $313K | Buy |
56,116
+1,116
| +2% | +$6.23K | ﹤0.01% | 3307 |
|
|
2024
Q3 | $348K | Sell |
55,000
-21,394
| -28% | -$135K | ﹤0.01% | 3189 |
|
|
2024
Q2 | $324K | Buy |
76,394
+20,000
| +35% | +$84.8K | ﹤0.01% | 2780 |
|
|
2024
Q1 | $409K | Sell |
56,394
-113,338
| -67% | -$822K | ﹤0.01% | 2946 |
|
|
2023
Q4 | $850K | Sell |
169,732
-201,544
| -54% | -$1.01M | ﹤0.01% | 2714 |
|
|
2023
Q3 | $1.56M | Buy |
371,276
+185,638
| +100% | +$782K | ﹤0.01% | 1807 |
|
|
2023
Q2 | $748K | Hold |
185,638
| – | – | ﹤0.01% | 2351 |
|
|
2023
Q1 | $523K | Hold |
185,638
| – | – | ﹤0.01% | 2615 |
|
|
2022
Q4 | $572K | Buy |
185,638
+181,978
| +4,972% | +$561K | ﹤0.01% | 2516 |
|
|
2022
Q3 | $11K | Buy |
+3,660
| New | +$11K | ﹤0.01% | 4121 |
|
|
2021
Q4 | – | Sell |
-319
| Closed | -$9K | – | 3229 |
|
|
2021
Q3 | $9K | Sell |
319
-885
| -74% | -$25K | ﹤0.01% | 3757 |
|
|
2021
Q2 | $47K | Sell |
1,204
-820
| -41% | -$32K | ﹤0.01% | 3413 |
|
|
2021
Q1 | $95K | Sell |
2,024
-1,224
| -38% | -$57.5K | ﹤0.01% | 3384 |
|
|
2020
Q4 | $128K | Sell |
3,248
-1,896
| -37% | -$74.7K | ﹤0.01% | 2887 |
|
|
2020
Q3 | $131K | Sell |
5,144
-3,040
| -37% | -$77.4K | ﹤0.01% | 2921 |
|
|
2020
Q2 | $597K | Buy |
8,184
+683
| +9% | +$49.8K | ﹤0.01% | 2229 |
|
|
2020
Q1 | $394K | Buy |
7,501
+1,108
| +17% | +$58.2K | ﹤0.01% | 2236 |
|
|
2019
Q4 | $522K | Buy |
6,393
+4,085
| +177% | +$334K | ﹤0.01% | 2661 |
|
|
2019
Q3 | $131K | Buy |
2,308
+1,275
| +123% | +$72.4K | ﹤0.01% | 3256 |
|
|
2019
Q2 | $123K | Buy |
1,033
+497
| +93% | +$59.2K | ﹤0.01% | 3474 |
|
|
2019
Q1 | $99K | Sell |
536
-1,979
| -79% | -$366K | ﹤0.01% | 3343 |
|
|
2018
Q4 | $450K | Buy |
2,515
+1,632
| +185% | +$292K | ﹤0.01% | 2317 |
|
|
2018
Q3 | $283K | Buy |
883
+738
| +509% | +$237K | ﹤0.01% | 2906 |
|
|
2018
Q2 | $58K | Sell |
145
-225
| -61% | -$90K | ﹤0.01% | 3250 |
|
|
2018
Q1 | $132K | Sell |
370
-492
| -57% | -$176K | ﹤0.01% | 3048 |
|
|
2017
Q4 | $341K | Sell |
862
-7,216
| -89% | -$2.85M | ﹤0.01% | 2339 |
|
|
2017
Q3 | $3.44M | Buy |
8,078
+8,036
| +19,133% | +$3.43M | ﹤0.01% | 954 |
|
|
2017
Q2 | $7K | Sell |
42
-998
| -96% | -$166K | ﹤0.01% | 3482 |
|
|
2017
Q1 | $131K | Buy |
+1,040
| New | +$131K | ﹤0.01% | 2716 |
|
|
2016
Q3 | – | Sell |
-8
| Closed | – | – | 3916 |
|
|
2016
Q2 | $0 | Buy |
+8
| New | – | ﹤0.01% | 3579 |
|
|
2015
Q4 | – | Sell |
-2
| Closed | – | – | 3197 |
|
|
2015
Q3 | $0 | Sell |
2
-6
| -75% | – | ﹤0.01% | 3944 |
|
|
2015
Q2 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 3990 |
|